Gallagher Neil
Former Director at ZYME; Officer at SNDX
- Sold, on record
- $72k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Feb 10, 2025
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SNDXNoticeFeb 10, 2025 2025
Filed to sell 4,618 shares ($72k)
Gallagher Neil, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale SNDXNo planFeb 10, 2025 same day
Sold 4,618 shares at $15.50 ($72k)
Gallagher Neil, President, Head of R&D
No 10b5-1 planSold 5.1% of holdings ($1.4M position)85,095 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice SNDXNoticeJul 10, 2025 +150 days
Filed to sell 9,679 shares ($90k)
Gallagher Neil, Officer
No 10b5-1 planFiling
- 4 Form 144 notice ZYMENoticeNov 21, 2025 +134 days
Filed to sell 105,000 shares ($2.5M)
Gallagher Neil, Former Director
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Nov 21, 2025 | ZYME | Former Director | Form 144 notice | 105,000 | $2.5M | Notice | SEC | |
| Jul 10, 2025 | Jul 10, 2025 | SNDX | Officer | Form 144 notice | 9,679 | $90k | Notice | SEC | |
| Feb 10, 2025 | Feb 12, 2025 | SNDX | President, Head of R&D | Form 4 sale | 4,618 | $72k | 5.1% | No plan | SEC |
| Feb 10, 2025 | Feb 10, 2025 | SNDX | Officer | Form 144 notice | 4,618 | $72k | Notice | SEC |